Curcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injury

被引:68
作者
Dohare, Preeti [1 ]
Varma, Saurabh [2 ]
Ray, Madhur [1 ]
机构
[1] Cent Drug Res Inst, Div Pharmacol, Lucknow 226001, Uttar Pradesh, India
[2] Indian Council Med Res, Inst Pathol, New Delhi, India
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2008年 / 19卷 / 01期
关键词
MCAo; transient focal ischemia; rat; apoptosis; TUNEL;
D O I
10.1016/j.niox.2008.04.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The antioxidant activity of C.oil in cerebral stroke has been reported earlier. We have attempted here to clarify the mechanisms underlying the neuroprotection against experimental cerebral ischemia by Curcuma oil (C.oil), isolated from the rhizomes of Curcuma longa. C.oil (250 mg/kg i.p.) was given 30 min before focal ischemia in rats caused by occlusion of the middle cerebral artery (1 h of occlusion, 24 h of reflow). Ischemia, leads to elevation in [Ca2+] this sets into motion a cascades of ischemic injury which was attenuated by C.oil. C.oil reduced post-ischemic brain neutrophil infiltration in the ischemic area, controlled tissue NOx levels and the neuronal levels of nitric oxide, peroxynitrite and reactive oxygen species when measured after 24 h of reflow. Double immunofluorescence staining analysis and Western immunoblot analysis with C.oil treatment showed that the expression of nitric oxide synthase (NOS) isoforms were decreased significantly compared to the untreated ischemia group. Ischemia is associated with increased in TUNEL (TdT-mediated dUTP nick-end labeling) positive cells in brain sections indicating DNA fragmentation. The C.oil treated group showed a significant decrease in numbers of apoptotic cells compared to the untreated ischemia group, as seen in the flowcytometric analysis of the neurons. Results of immunohistochemistry and Western immunoblot indicate that Coil suppressed the elevated protein level of Bax, and aided mitochondrial translocation and activation of Bcl-2 by altered mitochondrial membrane potential. It also inhibits the cytosolic release of apoptogenic molecules like cytochrome c, inhibits the activation of caspase-3 and the expression of p53 ultimately inhibiting apoptosis. Our observations suggest that high levels of NO generated by NOS isoforms are partially responsible for exacerbating the neuronal damage induced by MCAo by intraluminal filament. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 38 条
[1]
A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons [J].
Almeida, A ;
Bolaños, JP .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (02) :676-690
[2]
POLYMORPHONUCLEAR LEUKOCYTE INFILTRATION INTO CEREBRAL FOCAL ISCHEMIC TISSUE - MYELOPEROXIDASE ACTIVITY ASSAY AND HISTOLOGIC VERIFICATION [J].
BARONE, FC ;
HILLEGASS, LM ;
PRICE, WJ ;
WHITE, RF ;
LEE, EV ;
FEUERSTEIN, GZ ;
SARAU, HM ;
CLARK, RK ;
GRISWOLD, DE .
JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 29 (03) :336-345
[3]
APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[4]
Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species [J].
Crow, JP .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1997, 1 (02) :145-157
[5]
NITRIC-OXIDE MEDIATES GLUTAMATE NEUROTOXICITY IN PRIMARY CORTICAL CULTURES [J].
DAWSON, VL ;
DAWSON, TM ;
LONDON, ED ;
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6368-6371
[6]
RHODAMINE-123 AS A PROBE OF TRANSMEMBRANE POTENTIAL IN ISOLATED RAT-LIVER MITOCHONDRIA - SPECTRAL AND METABOLIC PROPERTIES [J].
EMAUS, RK ;
GRUNWALD, R ;
LEMASTERS, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 850 (03) :436-448
[7]
ESTEVEZ AG, 1995, J NEUROCHEM, V65, P1543
[8]
Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].
Feinklestein, SP ;
Fisher, M ;
Furland, AJ ;
Goldstein, LB ;
Gorelick, PB ;
Kaste, M ;
Lees, KR ;
Traystman, RJ ;
Albers, GW ;
Anwer, UE ;
Ashwood, T ;
Barone, FC ;
Basta, SL ;
Bogousslavsky, J ;
Buchan, AM ;
Cady, WJ ;
Chan, PH ;
Clemens, JA ;
Cox, BF ;
Craddock, RE ;
Cramer, SC ;
del Zoppo, GJ ;
Dielrich, WD ;
Elliott, P ;
Faden, AI ;
Feuerstein, GZ ;
Ginsberg, MD ;
Gold, M ;
Greene, WL ;
Hall, ED ;
Hsu, CY ;
Hunter, AJ ;
Lai, M ;
Lesko, LM ;
Levy, DE ;
Li, FH ;
Locke, KW ;
Lodge, D ;
Lowe, D ;
Marcoux, FW ;
McCulloch, J ;
McDermott, J ;
Meibach, R ;
Messersmith, EK ;
Moseley, M ;
Moskowitz, MA ;
Mueller, AL ;
Munro, F ;
Nudo, RJ ;
Oeda, J .
STROKE, 1999, 30 (12) :2752-2758
[9]
PROPHYLACTIC NEUROPROTECTION FOR CEREBRAL-ISCHEMIA [J].
FISHER, M ;
JONES, S ;
SACCO, RL .
STROKE, 1994, 25 (05) :1075-1080
[10]
The function of terpene natural products in the natural world [J].
Gershenzon, Jonathan ;
Dudareva, Natalia .
NATURE CHEMICAL BIOLOGY, 2007, 3 (07) :408-414